Skip to main content
. 2016 Feb 22;79(4):675–679. doi: 10.1021/acs.jnatprod.5b01016

Figure 3.

Figure 3

Trends in CHIKV inhibition as controlled through northern fragment substitution patterns of bryostatin-like analogues. (Left) Trends observed based on B-ring functionality of B-ring dioxane and the pyran series. (Right) Effects of A-ring functionality with P representing potency (in terms of cell-protective effects) and T representing toxicity. See text and Figure 1 for description of EC50 and CC50 values.